Vivani disclosed a definitive merger for its Cortigent unit and expects closing in Oct 2026; no sale price or cash terms were given, so this filing does not change Vivani's outlook.
The filing shows Vivani agreed to transfer its Cortigent unit to ClearOne but gives no sale price or cash terms. That lack of financial detail, plus a warning the deal may not close, leaves how Vivani's finances change unclear.
ClearOne will acquire Cortigent as a wholly owned subsidiary, expanding its business through that acquisition with closing expected in Oct 2026.
Follow Vivani Medical, Inc. (VANI) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for VANI